This webinar was recorded on Thursday, 5th September 2024.

Digital pathology tools, such as predictive and prognostic algorithms, can help facilitate increased efficiencies and improved patient outcomes. To date, conversations around digital pathology tools have understandably focused on the pathologist and lab. However, emerging DP tools are increasingly targeting clinical questions (rather than pathologist efficiencies), creating opportunities to include oncologists in discussions.

‍

During this webinar, we will discuss different perspectives on the hurdles to tool adoption, offer suggestions on how we can overcome these, and share insights from a lab medicine perspective, where we believe digital tools, such as workflow and diagnostics tools, can improve health outcomes.

‍

Speakers:

• Charles Gaulin, MD, Hematologist Oncologist at Dartmouth

• Joseph Annunziata, MD, Medical Director, Molecular Pathologist

• Omar Perez, PhD, Head of Medical Diagnostics at AstraZeneca

• Heinz-Josef Klümpen, MD, Medical Oncologist, Consultant at Amsterdam University Medical Center

‍

Moderators:

• Katie Maloney, DeciBio Consulting
• Esther Abels, SolarisRTC

‍

Learn more about DeciBio's Digital Pathology Market Report here: https://www.decibio.com/product/digital-pathology-market-report

‍

View the webinar recording below:

_{*Note that due to an error with Zoom—Katie Maloney has been incorrectly labeled as Omar Perez in the recording.}